Immunologic remission in rheumatoid arthritis, defined as the disappearance of anti-citrullinated protein antibodies and rheumatoid factor, was seen infrequently among patients achieving sustained clinical remission and did not correlate with the disappearance of symptoms, a long-term Dutch study found.
Dr. John Cush RheumNow
7 years 2 months ago
Are you an Expert in Still's disease, Periodic Fevers, FMF or Autoinflammatory Dz? Please let me know ASAP - I want to add you to the list! https://t.co/UwKkco8q1N
A head-to-head trial has shown that risankizumab was significantly superior to adalimumab in providing skin clearance (PASI90) in patients with moderate-to-severe plaque psoriasis, with no difference in safety signals between the two agents.
Dr. John Cush RheumNow
7 years 2 months ago
Studies analyzing the microbiome (by 16S ribosomal RNA bacterial gene testing) of 107 healthy subjects, and 696 twin pairs from the TwinsUK cohort shows that the microbiome is significantly and uniquely influenced by HLA- B27 and HLA–DRB1. https://t.co/vOJAjZD6bG
Dr. John Cush RheumNow
7 years 2 months ago
Abbvie has announced that the annual price for its new FDA approved JAK1 inhibitor, Rinvoq, will be $59,000. https://t.co/22LIetdTUh
Dr. John Cush RheumNow
7 years 2 months ago
Part 4 - War on RA - Desperado, the Eagles, Glenn Fry inspire Desperado to stop riding fences - on RheumNow; heres the video>> https://t.co/dgShcQpWHP or listen to the podcast on iTunes or here>> https://t.co/zEL85WKnyT
Dr. John Cush RheumNow
7 years 2 months ago
FDA approves Abbvies new JAK1 inhibitor - upadacitinib (named Rinvoq); Package insert - indicated for use in mod. to severely active RA not resp to MTX (do not combine w/ other JAKS, biologics). 15 mg qd. Warning for VTE, DVT. https://t.co/9KODynuWKC https://t.co/zRpeiaiTNS
Dr. John Cush RheumNow
7 years 2 months ago
RheumNow Podcast is up! Antibiotics causing RA? Watch here> https://t.co/tm5vpCtXpa or listen on iTunes or SoundCloud>> https://t.co/CbXpk4OUaS
Dr. John Cush RheumNow
7 years 2 months ago
Part 4 - War on RA - Desperado, the Eagles, Glenn Fry inspire Desperado to stop riding fences - on RheumNow; heres the video>> https://t.co/dgShcQpWHP or listen to the podcast on iTunes or here>> https://t.co/zEL85WKnyT
Dr. John Cush RheumNow
7 years 2 months ago
RheumNow Podcast is up! Antibiotics causing RA? Watch here>> https://t.co/tm5vpCtXpa or listen on iTunes or SoundCloud>> https://t.co/CbXpk4OUaS
Dr. John Cush RheumNow
7 years 2 months ago
Are you an Expert in Dx & management of Still's disease, Periodic Fevers, FMF or Autoinflammatory Dz? If so -- please Direct Message me and tell me where you are and who you want to see (Im developing an EXPERT Referral list). OR TELL ME who is person to see in your town! https://t.co/BGBRbn4yko
The US Food and Drug Administration (FDA) on Friday, August 16, approved AbbVie JAK1 inhibitor, Rinvoq (upadacitinib) for adults with rheumatoid arthritis with moderately to severely active disease either not responding to, or intolerant of, methotrexate (MTX).
Dr. John Cush RheumNow
7 years 2 months ago
CORRECTION: FDA approves Abbvies new JAK1 inhibitor - upadacitinib (named RINVOQ)
Dr. John Cush RheumNow
7 years 2 months ago
FDA approves Abbvies new JAK1 inhibitor - upadacitinib (named Rinvok) Package insert - indicated for use in mod. to severely active RA not resp to MTX (do not combine w/ other JAKS, biologics). 15 mg qd. Warning for VTE, DVT. https://t.co/9KODynuWKC https://t.co/zRpeiaiTNS
Dr. Jack Cush reports the news and important journal articles from the past week on RheumNow.com.
